Martin-Key Nayra A, Mirea Dan-Mircea, Olmert Tony, Cooper Jason, Han Sung Yeon Sarah, Barton-Owen Giles, Farrag Lynn, Bell Emily, Eljasz Pawel, Cowell Daniel, Tomasik Jakub, Bahn Sabine
Cambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
Princeton Neuroscience Institute, Princeton University, Princeton, NJ, United States.
JMIR Form Res. 2021 Oct 28;5(10):e27908. doi: 10.2196/27908.
Diagnosing major depressive disorder (MDD) is challenging, with diagnostic manuals failing to capture the wide range of clinical symptoms that are endorsed by individuals with this condition.
This study aims to provide evidence for an extended definition of MDD symptomatology.
Symptom data were collected via a digital assessment developed for a delta study. Random forest classification with nested cross-validation was used to distinguish between individuals with MDD and those with subthreshold symptomatology of the disorder using disorder-specific symptoms and transdiagnostic symptoms. The diagnostic performance of the Patient Health Questionnaire-9 was also examined.
A depression-specific model demonstrated good predictive performance when distinguishing between individuals with MDD (n=64) and those with subthreshold depression (n=140) (area under the receiver operating characteristic curve=0.89; sensitivity=82.4%; specificity=81.3%; accuracy=81.6%). The inclusion of transdiagnostic symptoms of psychopathology, including symptoms of depression, generalized anxiety disorder, insomnia, emotional instability, and panic disorder, significantly improved the model performance (area under the receiver operating characteristic curve=0.95; sensitivity=86.5%; specificity=90.8%; accuracy=89.5%). The Patient Health Questionnaire-9 was excellent at identifying MDD but overdiagnosed the condition (sensitivity=92.2%; specificity=54.3%; accuracy=66.2%).
Our findings are in line with the notion that current diagnostic practices may present an overly narrow conception of mental health. Furthermore, our study provides proof-of-concept support for the clinical utility of a digital assessment to inform clinical decision-making in the evaluation of MDD.
诊断重度抑郁症(MDD)具有挑战性,因为诊断手册未能涵盖该疾病患者认可的广泛临床症状。
本研究旨在为MDD症状学的扩展定义提供证据。
通过为一项三角研究开发的数字评估收集症状数据。使用具有嵌套交叉验证的随机森林分类法,利用特定疾病症状和跨诊断症状区分MDD患者和具有该疾病亚阈值症状的个体。还检查了患者健康问卷-9的诊断性能。
一个针对抑郁症的模型在区分MDD患者(n = 64)和亚阈值抑郁症患者(n = 140)时表现出良好的预测性能(受试者工作特征曲线下面积 = 0.89;敏感性 = 82.4%;特异性 = 81.3%;准确性 = 81.6%)。纳入精神病理学的跨诊断症状,包括抑郁症、广泛性焦虑症、失眠、情绪不稳定和恐慌症的症状,显著提高了模型性能(受试者工作特征曲线下面积 = 0.95;敏感性 = 86.5%;特异性 = 90.8%;准确性 = 89.5%)。患者健康问卷-9在识别MDD方面表现出色,但对该疾病存在过度诊断的情况(敏感性 = 92.2%;特异性 = 54.3%;准确性 = 66.2%)。
我们的研究结果与当前诊断实践可能对心理健康的概念界定过于狭窄这一观点一致。此外,我们的研究为数字评估在MDD评估中为临床决策提供信息的临床效用提供了概念验证支持。